Literature DB >> 31154664

Maternal Serum Lipid Trajectories and Association with Pregnancy Loss and Length of Gestation.

Katherine L Grantz1, Angelo Elmi2,3, Sarah J Pugh1, Janet Catov4, Lindsey Sjaarda1, Paul S Albert2,5.   

Abstract

OBJECTIVE: We characterized lipid trajectories and investigated lipids and rate of pregnancy lipid change with the risk of pregnancy loss or preterm delivery <37 weeks. STUDY
DESIGN: In a secondary analysis of 337 women with one to two prior losses assigned to placebo in a randomized controlled trial at four centers (2007-2012), cholesterol, low- and high-density lipoprotein cholesterol (HDL-C), and triglycerides were measured up to 6 months prepregnancy (time 0) and pregnancy up to 7 visits. Trajectories were created using linear mixed models. Multivariable logistic regression with adjustment for maternal characteristics and cholesterol was performed.
RESULTS: Lipids decreased from prepregnancy to 4 to 5 weeks, followed by an increase, and were biphasic or triphasic depending on the lipid component. Between 4 and 8 weeks, for every 1-unit increase in HDL-C, there was a 22% decreased odds of loss <14 weeks (odds ratio: 0.78; 95% confidence interval: 0.60, 0.99) and 24% decreased odds of loss or preterm delivery 14 to <37 weeks (odds ratio: 0.76; 95% confidence interval: 0.60, 0.96).
CONCLUSION: There were no associations with other lipid components or other time points. An impaired rise of HDL-C early in pregnancy may signal maladaptation to pregnancy that is associated with pregnancy loss or preterm delivery. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31154664      PMCID: PMC7558414          DOI: 10.1055/s-0039-1689000

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  26 in total

1.  Second-trimester loss and subsequent pregnancy outcomes: What is the real risk?

Authors:  Andrea G Edlow; Sindhu K Srinivas; Michal A Elovitz
Journal:  Am J Obstet Gynecol       Date:  2007-12       Impact factor: 8.661

2.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  Circulation       Date:  2018-11-10       Impact factor: 29.690

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Maternal lipid change in relation to length of gestation: a prospective cohort study with preconception enrollment of women.

Authors:  S Katherine Laughon; Alexander C McLain; Rajeshwari Sundaram; Janet M Catov; Germaine M Buck Louis
Journal:  Gynecol Obstet Invest       Date:  2013-12-11       Impact factor: 2.031

Review 5.  Lipid metabolism in pregnancy and its consequences in the fetus and newborn.

Authors:  Emilio Herrera
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 6.  Care for women with prior preterm birth.

Authors:  Jay D Iams; Vincenzo Berghella
Journal:  Am J Obstet Gynecol       Date:  2010-04-24       Impact factor: 8.661

7.  Monitoring cholesterol levels: measurement error or true change?

Authors:  Paul P Glasziou; Les Irwig; Stephane Heritier; R John Simes; Andrew Tonkin
Journal:  Ann Intern Med       Date:  2008-05-06       Impact factor: 25.391

8.  A proposed method to predict preterm birth using clinical data, standard maternal serum screening, and cholesterol.

Authors:  Brandon W Alleman; Amanda R Smith; Heather M Byers; Bruce Bedell; Kelli K Ryckman; Jeffrey C Murray; Kristi S Borowski
Journal:  Am J Obstet Gynecol       Date:  2013-03-15       Impact factor: 8.661

9.  Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.

Authors:  Enrique F Schisterman; Robert M Silver; Laurie L Lesher; David Faraggi; Jean Wactawski-Wende; Janet M Townsend; Anne M Lynch; Neil J Perkins; Sunni L Mumford; Noya Galai
Journal:  Lancet       Date:  2014-04-02       Impact factor: 79.321

Review 10.  Maternal lipid profile and the relation with spontaneous preterm delivery: a systematic review.

Authors:  Maryam Moayeri; Karst Y Heida; Arie Franx; Wilko Spiering; Monique W M de Laat; Martijn A Oudijk
Journal:  Arch Gynecol Obstet       Date:  2016-11-02       Impact factor: 2.344

View more
  1 in total

1.  Early pregnancy dyslipidemia is associated with placental DNA methylation at loci relevant for cardiometabolic diseases.

Authors:  Marion Ouidir; Xuehuo Zeng; Tsegaselassie Workalemahu; Deepika Shrestha; Katherine L Grantz; Pauline Mendola; Cuilin Zhang; Fasil Tekola-Ayele
Journal:  Epigenomics       Date:  2020-07-17       Impact factor: 4.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.